Engene Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.72

-0.02 (-1.15%)

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 10 53%

Hold 9 47%

Sell 0 0%

Price Target

Analyst Price Target +3,698.3% upside

Low Target $48.23

Average Target $65.33

High Target $96.03

Current Price $1.72

Current
$1.72

Target
$65.33

$48.23 $65.33 avg $96.03

Scenario Analysis

Bear Case

$48.23

2,704.1%

Low target

Base Case

$65.33

+3,698.3%

Avg target

Bull Case

$96.03

+5,483.1%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$12.25

-86.0% from high

52-Week Low

$1.40

+22.9% from low

Target vs 52W High

$65.33

+433.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%